Hui Li

Title: Innovations by Inventor Hui Li

Introduction

Hui Li is an accomplished inventor based in Cranston, RI (US). He has made significant contributions to the field of toxicity testing through his innovative patent. His work focuses on developing advanced systems that enhance the evaluation of drug safety and efficacy.

Latest Patents

Hui Li holds a patent for a multi-compartment device containing human three-dimensional (3D) microtissues for toxicity testing. This dual-compartment liver co-culture system exposes target microtissues to metabolites, allowing for the evaluation of toxicity using a standard multi-well plate for high throughput analysis. Discovery scientists can rapidly select lead compounds with desirable metabolic profiles, while safety scientists can determine the safety of drugs, pesticides, and environmental chemicals. This platform is allometrically scalable, enabling it to mimic the natural size differences between healthy organs and produce sufficient quantities of metabolites. The device is designed for immediate in vitro pathology assessment using confocal microscopy, transcriptomics, and proteomics.

Career Highlights

Hui Li's career is marked by his dedication to advancing scientific research and innovation. His work at Brown University has positioned him as a leader in the field of toxicology and drug safety assessment. He has successfully developed tools that facilitate the rapid assessment of compound safety, contributing to the overall improvement of public health.

Collaborations

Hui Li collaborates with notable colleagues, including Kim Boekelheide and Jeffrey R. Morgan. These partnerships enhance the research and development of innovative solutions in toxicity testing.

Conclusion

Hui Li's contributions to the field of toxicity testing through his innovative patent demonstrate his commitment to improving drug safety and efficacy. His work at Brown University continues to influence the landscape of scientific research and public health.